Logo image
A new model of LMP1-MYC interaction in B cell lymphoma
Journal article   Peer reviewed

A new model of LMP1-MYC interaction in B cell lymphoma

Evelena P Ontiveros, Ahmad Halwani, Laura L Stunz, Natalie Kamberos, Alicia K Olivier, Siegfried Janz and Gail A Bishop
Leukemia & lymphoma, Vol.55(12), pp.2917-2923
12/01/2014
DOI: 10.3109/10428194.2014.900762
PMCID: PMC4207734
PMID: 24605938

View Online

Abstract

Epstein-Barr virus (EBV) is associated with aggressive B cell lymphomas (BCLs). Latent membrane protein 1 (LMP1) of EBV is an oncogenic protein required for EBV B cell transformation. However, LMP1 is a weak oncogene in mice. Mice expressing Myc inserted 5' of the Eμ enhancer (iMyc Eμ ), mimicking the t(8;14) translocation of endemic Burkitt lymphoma, develop delayed onset BCLs. To investigate potential cooperation between LMP1 and oncogenic MYC, we produced mice expressing the LMP1 signaling domain via a hybrid CD40-LMP1 transgene (mCD40-LMP1), and the dysregulated MYC protein of aggressive EBV+ BCLs. mCD40-LMP1/iMyc Eμ mice trended toward earlier BCL onset. BCLs from mCD40-LMP1/iMyc Eμ mice expressed LMP1 and were transplantable into immunocompetent recipients. iMyc Eμ and mCD40-LMP1/iMyc Eμ mice developed BCLs with similar immunophenotypes. LMP1 signaling was intact in BCLs as shown by inducible interleukin-6. Additionally, LMP1 signaling to tumor cells induced the two isoforms of Pim1, a constitutively active prosurvival kinase implicated in lymphomagenesis.
LMP1 MYC lymphoma

Details

Logo image